Fenbendazole, commonly used in veterinary medicine, is being explored for human health applications. It’s primarily an anthelmintic that targets parasitic infections by inhibiting cellular glucose metabolism in worms. Recently, it has gained attention for potential anti-cancer effects, though human studies are limited. While some advocate for its off-label use, consultation with a healthcare professional is vital to evaluate risks and ensure informed decisions.
Recent Comments